These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12236804)

  • 41. [Comparative effectiveness of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity].
    Lipták J
    Ideggyogy Sz; 2013 Nov; 66(11-12):429. PubMed ID: 24555245
    [No Abstract]   [Full Text] [Related]  

  • 42. Managing spasticity with drugs.
    Simon O; Yelnik AP
    Eur J Phys Rehabil Med; 2010 Sep; 46(3):401-10. PubMed ID: 20927006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A mixed treatment comparison on efficacy and safety of treatments for spasticity caused by multiple sclerosis: a systematic review and network meta-analysis.
    Fu X; Wang Y; Wang C; Wu H; Li J; Li M; Ma Q; Yang W
    Clin Rehabil; 2018 Jun; 32(6):713-721. PubMed ID: 29582713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The usefulness of tizanidine. A one-year follow-up of the treatment of spasticity in infantile cerebral palsy].
    Vásquez-Briceño A; Arellano-Saldaña ME; León-Hernández SR; Morales-Osorio MG
    Rev Neurol; 2006 Aug 1-15; 43(3):132-6. PubMed ID: 16871477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost effectiveness of oromucosal cannabis-based medicine (Sativex®) for spasticity in multiple sclerosis.
    Lu L; Pearce H; Roome C; Shearer J; Lang IA; Stein K
    Pharmacoeconomics; 2012 Dec; 30(12):1157-71. PubMed ID: 23072659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of spasticity].
    Autti-Rämö I
    Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
    [No Abstract]   [Full Text] [Related]  

  • 47. The assessment of drug treatment of spastic gait.
    Corston RN; Johnson F; Godwin-Austen RB
    J Neurol Neurosurg Psychiatry; 1981 Nov; 44(11):1035-9. PubMed ID: 7038051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of tizanidine in the treatment of spasticity.
    Neurology; 1994 Nov; 44(11 Suppl 9):S1-80. PubMed ID: 7970005
    [No Abstract]   [Full Text] [Related]  

  • 49. [Current data on bipolar disorders, epilepsy and spasticity. 4. Neuro-Forum, Dresden].
    Fortschr Neurol Psychiatr; 1999 May; 67(5 Suppl Aktuelles):1-12. PubMed ID: 10368778
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug treatments for spasticity.
    Yelnik AP; Simon O; Bensmail D; Chaleat-Valayer E; Decq P; Dehail P; Quentin V; Marque P; Parratte B; Pellas F; Rousseaux M; Trocello JM; Uzzan M; Dumarcet N;
    Ann Phys Rehabil Med; 2009 Dec; 52(10):746-56. PubMed ID: 19892619
    [No Abstract]   [Full Text] [Related]  

  • 51. Development of a simple spasticity quantification method: effects of tizanidine on spasticity in patients with sequelae of cerebrovascular disease.
    Ogawa N; Asanuma M; Hirata H; Ota Z; Yamawaki Y; Yamamoto M
    J Int Med Res; 1992 Feb; 20(1):78-86. PubMed ID: 1568522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.
    Chou R; Peterson K; Helfand M
    J Pain Symptom Manage; 2004 Aug; 28(2):140-75. PubMed ID: 15276195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intrathecal baclofen in multiple sclerosis: too little, too late?
    Erwin A; Gudesblatt M; Bethoux F; Bennett SE; Koelbel S; Plunkett R; Sadiq S; Stevenson VL; Thomas AM; Tornatore C; Zaffaroni M; Hughes M
    Mult Scler; 2011 May; 17(5):623-9. PubMed ID: 21282321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Open-label dose-titration safety and efficacy study of tizanidine hydrochloride in the treatment of spasticity associated with chronic stroke.
    Gelber DA; Good DC; Dromerick A; Sergay S; Richardson M
    Stroke; 2001 Aug; 32(8):1841-6. PubMed ID: 11486114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tizanidine in the management of spasticity and musculoskeletal complaints in the palliative care population.
    Smith HS; Barton AE
    Am J Hosp Palliat Care; 2000; 17(1):50-8. PubMed ID: 11094920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?
    Freitag FG
    CNS Drugs; 2003; 17(6):373-81. PubMed ID: 12696998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tizanidine as treatment of spasticity in patients with hemiplegia caused by a CVA or brain injury].
    Weynants L; Van Laere M
    Acta Belg Med Phys; 1990; 13(1):19-22. PubMed ID: 2336897
    [No Abstract]   [Full Text] [Related]  

  • 58. Tizanidine vs. baclofen in the treatment of spasticity in patients with multiple sclerosis.
    Rice GP
    Can J Neurol Sci; 1989 Nov; 16(4):451. PubMed ID: 2804809
    [No Abstract]   [Full Text] [Related]  

  • 59. A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia.
    Bes A; Eyssette M; Pierrot-Deseilligny E; Rohmer F; Warter JM
    Curr Med Res Opin; 1988; 10(10):709-18. PubMed ID: 3286129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Randomized, Placebo-Controlled Trial of Ibuprofen Plus Metaxalone, Tizanidine, or Baclofen for Acute Low Back Pain.
    Friedman BW; Irizarry E; Solorzano C; Zias E; Pearlman S; Wollowitz A; Jones MP; Shah PD; Gallagher EJ
    Ann Emerg Med; 2019 Oct; 74(4):512-520. PubMed ID: 30955985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.